Legfrissebb próbák


EudraCT Number: 2004-000337-12 Sponsor Protocol Number: 24810 Start Date: 2004-07-23
Sponsor Name: Serono International SA
Full Title: A multicentre, single arm, open-label, phase IV study to evaluate the immunogenicity and safety of subcutaneously administered r-hIFN beta-1a (Rebif) using clone 484-39 in the treatment of subjects...
Medical condition: MS with 2 or more relapses within the last 2 years
Disease: Version SOC Term Classification Code Term Level
7.0 10028245 PT
Population Age: Adults Gender: Male, Female
Trial protocol: HU (Completed)
Trial results: View results

EudraCT Number: 2004-000362-12 Sponsor Protocol Number: K-832-2.01EU Start Date: 2004-07-23
Sponsor Name: Kowa Research Europe Ltd
Full Title: A Double-Blind, Randomised, Dose-Ranging Study to Compare K-832 with Placebo in the treatment of Patients with Active Rheumatoid Arthritis
Medical condition: Rheumatoid Arthritis
Disease: Version SOC Term Classification Code Term Level
6.0 10028395 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: CZ (Completed)
Trial results: View results
EudraCT Number: 2004-001901-81 Sponsor Protocol Number: AISAR-01-04 Start Date: 2004-07-23
Sponsor Name: AISAR ASSOCIAZIONE ITALIANA PER LO STUDIO DEGLI ANTIMICROBICI E DELLE RESISTENZE
Full Title: Efficacy and tollerability of thiamphenicol glycinate acetylcysteinate, given in sequential therapy sistematic and aerosol or by aerosol in the treatment of hight respiratory tract acute infectio...
Medical condition: terapia sequenziale sistemica ed aerosol delle infezioni acute e/o subacute/ricorrenti delle alte vie respiratorie
Disease: Version SOC Term Classification Code Term Level
6.1 10004018 HLGT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Prematurely Ended)
Trial results: (No results available)

EudraCT Number: 2004-000772-14 Sponsor Protocol Number: TKT027 Start Date: 2004-07-23
Sponsor Name: TKT Inc
Full Title: A Phase I-II Pharmacokinetic/Pharmacodynamic Study of Replagal to Assess the Effects of Alternative Dose and Regimen in Patients with Fabry Disease (TKT027)
Medical condition: Fabry Disease
Disease: Version SOC Term Classification Code Term Level
6.1 10016016 PT
Population Age: Adults Gender: Male
Trial protocol: CZ (Completed)
Trial results: (No results available)
EudraCT Number: 2004-000830-35 Sponsor Protocol Number: RIS-SCH-3007 Start Date: 2004-07-23
Sponsor Name: JANSSEN-CILAG
Full Title: Maintenance of the clinical response with long-acting injectable Risperidone in patients with Schizophrenia or schizoaffective disorders
Medical condition: Schizophrenia or schizoaffective disorder
Disease: Version SOC Term Classification Code Term Level
6.1 10039621 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results

EudraCT Number: 2004-001362-40 Sponsor Protocol Number: CSTI571BIT15 Start Date: 2004-07-22
Sponsor Name: NOVARTIS FARMA
Full Title: PHASE II STUDY OF IMATINIB MESYLATE IN CHORDOMA
Medical condition: Treatment of advanced or unresectable chordoma
Disease: Version SOC Term Classification Code Term Level
6.1 10008747 PT
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2004-000311-26 Sponsor Protocol Number: 0431-019 Start Date: 2004-07-21
Sponsor Name: Merck & Co., Inc.
Full Title: A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Addition of MK-0431 to Patients with Type 2 Diabetes Mellitus who Have Inadequate Glycemic Control on Piogli...
Medical condition: Type 2 Diabetes Mellitus
Disease: Version SOC Term Classification Code Term Level
7.0 10045242 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) AT (Completed) IT (Completed) DK (Completed)
Trial results: View results

EudraCT Number: 2004-000313-19 Sponsor Protocol Number: 0431-021 Start Date: 2004-07-21
Sponsor Name: Merck & Co., Inc.
Full Title: A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of MK-0431 Monotherapy in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control
Medical condition: Type 2 Diabetes Mellitus
Disease: Version SOC Term Classification Code Term Level
7.0 10045242 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) GB (Completed)
Trial results: View results
EudraCT Number: 2004-000625-30 Sponsor Protocol Number: INOT22 Start Date: 2004-07-21
Sponsor Name: INO Therapeutics
Full Title: Comparison of Supplemental Oxygen and Nitric Oxide for Inhalation Plus Oxygen in the Evaluation of the Reactivity of the Pulmonary Vasculature During Acute Pulmonary Vasodilator Testing
Medical condition: : Nitric Oxide for inhalation at 800ppm, plus 100% O2, to be used to assess pulmonary vaso reactivity during Pulmonary Vasodilator Testing
Disease: Version SOC Term Classification Code Term Level
Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: ES (Completed) GB (Completed)
Trial results: View results

EudraCT Number: 2004-002302-30 Sponsor Protocol Number: 83/2004/U/Sper Start Date: 2004-07-20
Sponsor Name: AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Full Title: FMZ Fludarabine, Mitoxantrone, Zevalin regimen a phase II study as front-line treatment in indolent non-follicular non-Hodgkins lymphoma patients
Medical condition: Confirmed histologic diagnosis according to the REAL classification of B-cell indolent lymphoma including small lymphocytic, immunocytoma, and marginal zone lymphoma
Disease: Version SOC Term Classification Code Term Level
6.1 10003900 HLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: (No results available)
3
Iratkozz fel